Evaluation of colorectal cancer awareness of pharmacy faculty students
A. M. Aliyevа, Elif Aras‐Atik, Kamer Tecen-Yücel
tr (code pays fourni par la source)
0 citations
BMC Medical Education
Elif Aras‐Atik
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
13Publications signalées
75Citations signalées
2Affiliations récentes
Les institutions déclarées
Les domaines associés
COVID-19 Clinical Research StudiesPharmaceutical Practices and Patient OutcomesNeutropenia and Cancer InfectionsMedication Adherence and ComplianceSARS-CoV-2 and COVID-19 Research
Les publications récentes
Medication regimen complexity in cancer patients: an overlooked issue for healthcare team
Sude Ayça Çifci, Elif Aras‐Atik, Ömer Dızdar, Aygin Bayraktar‐Ekincioglu
tr (code pays fourni par la source)
5 citations
Supportive Care in Cancer
Medication regimen complexity in cancer patients: an overlooked issue for healthcare team
Sude Ayça Çifci, Elif Aras‐Atik, Ömer Dızdar, Aygin Bayraktar‐Ekincioglu
tr (code pays fourni par la source)
0 citations
Research Square
Yoğun Bakımda Bireyseleştirilmiş İlaç Tedavisi
Umay Merve Güven, Burcu Kelleci Çakır, Nadir Yalçın, Elif Aras‐Atik et autres
tr, cz, de (code pays fourni par la source)
1 citation
Advers İlaç Reaksiyonları Yönetimi
0 citations
International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions
Andrew Walker, Alexandre Chan, Constanza Cortés Labra, Mário L de Lemos et autres
gb, us, ca, es, tr, bn, Nigéria, id, th (code pays fourni par la source)
3 citations
Journal of Oncology Pharmacy Practice
International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer care
Lisa M. Holle, Tegan Bilse, Ramatu Masud Alabelewe, Polly E. Kintzel et autres
us, Afrique du Sud, Nigéria, sg, Kenya, ca, th, id, Zimbabwe, tr (code pays fourni par la source)
37 citations
Journal of Oncology Pharmacy Practice
Does therapeutic drug monitoring of hydroxychloroquine improve treatment outcome in intensive care unit patients with COVID‐19?
Kamer Tecen-Yücel, Elif Aras‐Atik, Aygin Bayraktar‐Ekincioglu
tr (code pays fourni par la source)
4 citations
International Journal of Clinical Practice
Can Alpha-1 Antitrypsin Levels be Used to Predict the Prognosis of COVID-19 Therapy?
Elif Aras‐Atik, Nesligül Özdemir, Kutay Demirkan
tr (code pays fourni par la source)
3 citations
Turkish Journal of Pharmaceutical Sciences
Are we aware of potential interactions between drugs used in lung cancer and drugs used in the treatment of COVID-19?
Elif Aras‐Atik, Kamer Tecen-Yucel, Aygin Bayraktar‐Ekincioglu
tr (code pays fourni par la source)
1 citation
Journal of Oncology Pharmacy Practice
Risk assessment of febrile neutropenia and evaluation of G-CSF use in patients with cancer: a real-life study
Elif Aras‐Atik, Aygin Bayraktar‐Ekincioglu, Saadettin Kılıçkap
tr (code pays fourni par la source)
17 citations
Supportive Care in Cancer
Capecitabine Induced Hand-Foot Syndrome: A Systematic Review of Case Reports
Elif Aras‐Atik, Kamer Tecen-Yücel, Aygin Bayraktar‐Ekincioglu, İbrahim Güllü
tr (code pays fourni par la source)
5 citations
Clinical and Experimental Health Sciences
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.